Melox

Meloxicam, the active ingredient in Melox, is a nonsteroidal anti-inflammatory drug (NSAID) presented as an oral tablet for systemic use. It reduces inflammation and pain in musculoskeletal conditions such as osteoarthritis, rheumatoid arthritis, ankylosing spondylitis, and acute pain episodes among adult patients.

GNH USA supplies Melox as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to EU quality standards and providing reliable logistics for global distribution, including temperature‑controlled shipping where required and comprehensive regulatory support.

Melox (meloxicam) is used to manage inflammatory and painful conditions affecting the musculoskeletal system.

Osteoarthritis: reduces joint pain and improves functional ability. Rheumatoid arthritis: decreases synovial inflammation and slows disease progression. Ankylosing spondylitis: alleviates spinal pain and stiffness. Acute pain: provides short‑term relief of moderate to severe pain.

Melox may cause a range of adverse reactions, which are grouped by frequency and severity.

Common Side Effects: - Gastrointestinal discomfort (indigestion, nausea, abdominal pain). - Headache. - Dizziness. - Mild skin rash.

Serious or Rare Side Effects: - Peptic ulcer bleeding. - Severe hepatic injury. - Anaphylactic reactions.

Before prescribing Melox, clinicians should consider several safety measures.

Assess renal function: evaluate kidney status before initiating therapy and periodically during treatment. Monitor gastrointestinal health: watch for signs of ulceration or bleeding. Avoid in patients with known hypersensitivity to meloxicam or other NSAIDs. Use lowest effective dose: limit duration to the shortest time needed for symptom control. Avoid concomitant use with other NSAIDs or anticoagulants: increases bleeding risk. Store at room temperature: keep in original container, protect from moisture and direct sunlight.

Melox can interact with other medicines; some combinations should be avoided while others require close monitoring.

Major Interactions (Avoid): - Anticoagulants (e.g., warfarin): increased risk of bleeding. - Lithium: meloxicam may raise lithium levels, risking toxicity. - Methotrexate: reduced clearance may lead to toxicity.

Moderate Interactions (Monitor Closely): - ACE inhibitors or ARBs: may impair renal function; monitor creatinine. - Diuretics: can enhance renal effects; monitor electrolytes. - SSRIs or SNRIs: additive bleeding risk; observe for signs of hemorrhage.